Steris | STE - Operating Expenses


Steris reported $1.27B in Operating Expenses for its fiscal quarter ending in March of 2026.





Operating Expenses Change Date
3M USD 4.89B 1.62B Jun/2026
Accuray USD 37.18M 567K Dec/2024
Baxter International USD 2.68B 3.36B Jun/2026
Becton, Dickinson and Co. USD 24.13B 19.54B Mar/2026
Boston Scientific USD 4.2B 49M Jun/2026
CONMED USD 307.08M 15.45M Jun/2026
Cooper Companies USD 1.11B 301.2M Mar/2026
Dexcom USD 990.1M 53.5M Jun/2026
Ecolab USD 3.61B 220M Jun/2026
Edwards Lifesciences USD 1.22B 87.6M Jun/2026
Fortive USD 886.9M 9.2M Jun/2026
Getinge SEK 7.03B 2.96B Jun/2026
Globus Medical USD 595.85M 49.26M Mar/2026
Haemonetics USD 134.99M 1.26M Dec/2025
Idexx Laboratories USD 791.02M 12.78M Jun/2026
Inogen USD 49.14M 665K Sep/2024
Insulet USD 672M 32.3M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
Intuitive Surgical USD 1.91B 3.6M Jun/2026
J&J USD 17.83B 388M Jun/2026
Olympus JPY 268.42B 35.37B Mar/2026
Orthofix International USD 213.79M 12.36M Dec/2025
Owens Minor USD -464.76M 1.17B Mar/2026
ResMed USD 925.74M 525K Mar/2026
Steris USD 1.27B 51.5M Mar/2026
Stryker USD 4.8B 118M Jun/2026
Tandem Diabetes Care USD 282.09M 9.97M Dec/2025
Teleflex USD 3.08B 2.55B Mar/2026
Thermo Fisher Scientific USD 9.81B 716M Jun/2026
Zimmer Biomet Holdings USD 1.83B 140.7M Jun/2026